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base. Data was analyzed using a CHAID (Chi-square automatic
interaction detection) technique. RESULTS: The average MPR
of the sampled population (n = 181) was 0.62. CHAID analysis
segmented the sample into groups at a perceived beneﬁt value of
3.85 and a cost of $19.50. Patients with a perceived beneﬁt
below 3.85 had a signiﬁcantly lower MPR (0.26, p < 0.000) 
than patients with a perceived beneﬁt over.3.5 (MPR = 0.66).
Among patients in the higher perceived beneﬁt group, those
paying more than $19.50 per prescription had a signiﬁcantly
lower MPR (0.54, p < 0.000) than patients paying less than
$19.50 (MPR = 0.78). However, cost had no impact among
patients with a lower perceived beneﬁt. CONCLUSIONS: Per-
ceived beneﬁt and cost signiﬁcantly affected medication compli-
ance. Individuals with a high perceived beneﬁt were further
impacted by cost; no such effect was observed in individuals with
low perceived beneﬁt.
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OBJECTIVES: To rationalize the clinical use of albumin in order
to reduce inappropriate subministration and minimize costs in a
300-beds community hospital. METHODS: A multidisciplinary
team composed by the Chief Medical Ofﬁcer, the Intensive Care
Unit Director, the Immunostransfusional Unit Director, the
Farmacy Director, elaborated a clinical practice protocol on 
the prescription of albumin and a speciﬁc form for it request 
to Farmacy. Clinical indications for albumin use were deﬁned
according to a method which combined a review of the medical
literature with experts points of view. First choice criteria were
paracentesis, bacterial peritonitis, plasmapheresys, liver-kidney
disease, liver transplant; second choice criteria were hypo-
volaemia, burns, haemolitical neonatal syndrome. Protocol dis-
semination and implementation started in October, 2003. The
method for assessing the impact was a pre-post analysis of the
discrepancies between recommendations and clinical practice
(2003-ﬁrst semester versus 2004-ﬁrst semester). Results were
tested by chi-square test (X2). RESULTS: A 55% decrease in 100
g/l-phials of albumin prescription was found in 2004 with
respect to 2003 (X2 = 211.92; df = 1; p < 0.001). In particular
the 25g/l- threshold for subministration was respected in 75.3%
cases in all. Signiﬁcative reduction of inappropriate utilization
was found in cirrosis patients (X2 = 22.28; df = 1; p < 0.001),
hypoalbuminaemia conditions (X2 = 23.31; df = 1; p < 0.005)
and haedema impairment (X2 = 87.09; df = 1; p < 0.001). The
expenditure for albumin decrease from 48.910€ ($65,510.05) to
21.629€ ($28,969.88) without any negative outcomes referred.
CONCLUSION: Shared multidisciplinary protocol signiﬁcantly
improved appropriateness of albumin utilization and expendi-
ture rationalization preserving positive outcome. It appeared to
be a simple health technology that improved hospital efﬁciency
in a short time. Multidisciplinary and sharing of information are
supposed to be the key tools for this success.
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OBJECTIVE: To describe a visually-friendly approach (Drug-O-
Gram) for summarizing patterns of drug use over time using
medications to treat two common disease conditions—arthritis
and hypertension. METHODS: Administrative claims data
(Medstat MarketScan) was used to identify hypertensive patients
newly treated with diuretics, angiotensin-receptor blockers
[ARB], or calcium-channel blockers [CCB]; and arthritis patients
newly treated with cyclooxygenase-2 [COX-2] inhibitors or 
traditional non-steroidal anti-inﬂammatory drugs [NSAID]).
Patients were then classiﬁed according to medication class use
during each subsequent day for one year. The Drug-O-Gram
plots the distribution of drug use over the follow-up period. Sta-
tistical smoothing was applied to the plots to help visualize
trends over time. Superimposed on the plots are plots of outpa-
tient medical costs impacted by medication use. RESULTS:
Among patients with hypertension, the percent of days on med-
ication was higher for ARBs (65%) compared to CCBs (59%)
and diuretics (48%). Additionally, outpatient medical payments
for ARB patients were 69% of diuretic and 56% of CCB out-
patient payments. Among patients with arthritis, discontinuation
was faster and persistency worse for traditional NSAIDs than for
the COX-2 inhibitors. CONCLUSIONS: The Drug-O-Gram
graphically summarizes drug use over time by ﬁtting graphical
smooths to daily averages. It then stacks these graphs to visual-
ize changes between medications. These plots convey more detail
of drug use patterns than commonly used discontinuation and
switching rates. Areas under the plots can be used to quantify
and analyze the amounts and changes of drug use over time. By
superimposing daily plots of other outcomes, one can assess their
relationship to drug use.
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OBJECTIVES: To examine the prevalence of drug noncompli-
ance among TRICARE beneﬁciaries, the reasons for it, costs
associated with unclaimed prescriptions, and how pharmacy fea-
tures inﬂuence compliance in the Military Health System (MHS).
METHODS: We conducted interviews with staff at six pharma-
cies, a telephone survey of 1214 TRICARE beneﬁciaries, and
analysis of pharmacy data. Pharmacy interviews provided infor-
mation on the average level of noncompliance and features dis-
tinctive to each site. We asked beneﬁciaries to report on their
prescription compliance in the year prior to the survey and
reasons for noncompliance. We used claims data to examine uti-
lization among noncompliers and the direct cost of unclaimed
prescriptions. RESULTS: After weighting survey responses at the
six study pharmacies, approximately 8% of beneﬁciaries failed
to pick up at least one prescription in the year before the survey.
Noncompliance was most prevalent among young, active duty
personnel and less so among older, retired beneﬁciaries. Non-
compliers were more likely than compliers to have had an emer-
gency room visit in the last year (12.3% versus 6.6%). The total
annual estimated costs of unclaimed prescriptions in additional
labor and discarded drugs is roughly $50,000, per 1,000,000
beneﬁciaries. The most common reasons for non-compliance
included long wait times at the pharmacy (11.1% of non-
compliers), the perception that the prescription was not needed
(18.5%), and patient forgetfulness (17.3%). The primary phar-
macy features that inﬂuence noncompliance include long wait
times, the dispensing process used at the pharmacy, patient
reminder calls, and providers not receiving automated messages
about non-compliant prescriptions. CONCLUSION: Policy rec-
